Global Tuberculosis Drug Market Insights, Forecast to 2025

Tuberculosis (TB) is an infectious disease, which is caused by Mycobacterium tuberculosis. These bacteria generally infect human lungs. However, it can infect other body parts/organs as well. Three major types of tuberculosis are found: latent, active, and drug-resistant tuberculosis. Symptoms are not identifiable in case of latent tuberculosis, due to presence of an inactive form of bacteria. In active tuberculosis, symptoms are clearly visible and they can spread from one person to another. Coughing for more than two weeks, chest pain, coughing up blood, chills, fatigue, unintentional weight loss, fever, and loss of appetite are some of the common symptoms of active tuberculosis. HIV/AIDS, severe kidney disease, cancer, diabetes, and malnutrition are some of the key risk factors generally found to be associated with tuberculosis.
Growing prevalence of multi-drug resistant tuberculosis is driving the tuberculosis drugs market. Drug shortages is a major restraint for the tuberculosis drugs market, especially in low- to medium-income countries of the world. Tuberculosis associated with diseases such as HIV/AIDS and conditions such as obesity is extremely difficult to manage. The tuberculosis drugs market can be segmented based on drug class, disease type, end-user, and region. In terms of drug class, the market can be categorized into first-line therapy, second-line therapy, and combination therapy. Isoniazid, Pyrazinamide, Rifampin, and Ethambutol majorly constitute the first-line therapy for TB; while Streptomycin, Capreomycin, Ethionamide, Levofloxacin, and Gatifloxacin are generally considered as a part of the second-line therapy. Second-line therapy is expected to be a rapidly growing segment of the tuberculosis drugs market.
The global Tuberculosis Drug market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Tuberculosis Drug market based on company, product type, end user and key regions.

This report studies the global market size of Tuberculosis Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Tuberculosis Drug in these regions.
This research report categorizes the global Tuberculosis Drug market by top players/brands, region, type and end user. This report also studies the global Tuberculosis Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Lupin
Otsuka Novel Products
Pfizer
Sanofi

Market size by Product
First-line Anti-TB Drugs
Second-line Anti-TB Drugs
Market size by End User
Active TB
Latent TB

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Tuberculosis Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Tuberculosis Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Tuberculosis Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Tuberculosis Drug submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Tuberculosis Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Tuberculosis Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Tuberculosis Drug Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Tuberculosis Drug Market Size Growth Rate by Product
1.4.2 First-line Anti-TB Drugs
1.4.3 Second-line Anti-TB Drugs
1.5 Market by End User
1.5.1 Global Tuberculosis Drug Market Size Growth Rate by End User
1.5.2 Active TB
1.5.3 Latent TB
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Tuberculosis Drug Market Size
2.1.1 Global Tuberculosis Drug Revenue 2014-2025
2.1.2 Global Tuberculosis Drug Sales 2014-2025
2.2 Tuberculosis Drug Growth Rate by Regions
2.2.1 Global Tuberculosis Drug Sales by Regions
2.2.2 Global Tuberculosis Drug Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Tuberculosis Drug Sales by Manufacturers
3.1.1 Tuberculosis Drug Sales by Manufacturers
3.1.2 Tuberculosis Drug Sales Market Share by Manufacturers
3.1.3 Global Tuberculosis Drug Market Concentration Ratio (CR5 and HHI)
3.2 Tuberculosis Drug Revenue by Manufacturers
3.2.1 Tuberculosis Drug Revenue by Manufacturers (2014-2019)
3.2.2 Tuberculosis Drug Revenue Share by Manufacturers (2014-2019)
3.3 Tuberculosis Drug Price by Manufacturers
3.4 Tuberculosis Drug Manufacturing Base Distribution, Product Types
3.4.1 Tuberculosis Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Tuberculosis Drug Product Type
3.4.3 Date of International Manufacturers Enter into Tuberculosis Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Tuberculosis Drug Sales by Product
4.2 Global Tuberculosis Drug Revenue by Product
4.3 Tuberculosis Drug Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Tuberculosis Drug Breakdown Data by End User

6 North America
6.1 North America Tuberculosis Drug by Countries
6.1.1 North America Tuberculosis Drug Sales by Countries
6.1.2 North America Tuberculosis Drug Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Tuberculosis Drug by Product
6.3 North America Tuberculosis Drug by End User

7 Europe
7.1 Europe Tuberculosis Drug by Countries
7.1.1 Europe Tuberculosis Drug Sales by Countries
7.1.2 Europe Tuberculosis Drug Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Tuberculosis Drug by Product
7.3 Europe Tuberculosis Drug by End User

8 Asia Pacific
8.1 Asia Pacific Tuberculosis Drug by Countries
8.1.1 Asia Pacific Tuberculosis Drug Sales by Countries
8.1.2 Asia Pacific Tuberculosis Drug Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Tuberculosis Drug by Product
8.3 Asia Pacific Tuberculosis Drug by End User

9 Central & South America
9.1 Central & South America Tuberculosis Drug by Countries
9.1.1 Central & South America Tuberculosis Drug Sales by Countries
9.1.2 Central & South America Tuberculosis Drug Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Tuberculosis Drug by Product
9.3 Central & South America Tuberculosis Drug by End User

10 Middle East and Africa
10.1 Middle East and Africa Tuberculosis Drug by Countries
10.1.1 Middle East and Africa Tuberculosis Drug Sales by Countries
10.1.2 Middle East and Africa Tuberculosis Drug Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Tuberculosis Drug by Product
10.3 Middle East and Africa Tuberculosis Drug by End User

11 Company Profiles
11.1 Lupin
11.1.1 Lupin Company Details
11.1.2 Company Business Overview
11.1.3 Lupin Tuberculosis Drug Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Lupin Tuberculosis Drug Products Offered
11.1.5 Lupin Recent Development
11.2 Otsuka Novel Products
11.2.1 Otsuka Novel Products Company Details
11.2.2 Company Business Overview
11.2.3 Otsuka Novel Products Tuberculosis Drug Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Otsuka Novel Products Tuberculosis Drug Products Offered
11.2.5 Otsuka Novel Products Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Company Business Overview
11.3.Pfizer Tuberculosis Drug Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Pfizer Tuberculosis Drug Products Offered
11.3.5 Pfizer Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Company Business Overview
11.4.3 Sanofi Tuberculosis Drug Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Sanofi Tuberculosis Drug Products Offered
11.4.5 Sanofi Recent Development

12 Future Forecast
12.1 Tuberculosis Drug Market Forecast by Regions
12.1.1 Global Tuberculosis Drug Sales Forecast by Regions 2019-2025
12.1.2 Global Tuberculosis Drug Revenue Forecast by Regions 2019-2025
12.2 Tuberculosis Drug Market Forecast by Product
12.2.1 Global Tuberculosis Drug Sales Forecast by Product 2019-2025
12.2.2 Global Tuberculosis Drug Revenue Forecast by Product 2019-2025
12.3 Tuberculosis Drug Market Forecast by End User
12.4 North America Tuberculosis Drug Forecast
12.5 Europe Tuberculosis Drug Forecast
12.6 Asia Pacific Tuberculosis Drug Forecast
12.7 Central & South America Tuberculosis Drug Forecast
12.8 Middle East and Africa Tuberculosis Drug Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Tuberculosis Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables and Figures

Figure Tuberculosis Drug Product Picture
Table Tuberculosis Drug Market Segments
Table Key Manufacturers Tuberculosis Drug Covered
Table Global Tuberculosis Drug Market Size Growth Rate by Product 2019-2025 (K MT) & (Million US$)
Figure Global Tuberculosis Drug Sales Market Share by Product 2014-2025
Figure First-line Anti-TB Drugs Product Picture
Table Major Manufacturers of First-line Anti-TB Drugs
Figure Second-line Anti-TB Drugs Product Picture
Table Major Manufacturers of Second-line Anti-TB Drugs
Table Global Tuberculosis Drug Market Size Growth Rate by End User 2019-2025 (K MT)
Figure Active TB
Figure Latent TB
Figure Tuberculosis Drug Report Years Considered
Figure Global Tuberculosis Drug Market Size 2014-2025 (Million US$)
Figure Global Tuberculosis Drug Sales 2014-2025 (K MT)
Table Global Tuberculosis Drug Market Size by Regions 2014-2019 (K MT) & (Million US$)
Table Global Tuberculosis Drug Sales by Regions 2014-2019 (K MT)
Table Global Tuberculosis Drug Sales Market Share by Regions 2014-2019
Figure Global Tuberculosis Drug Sales Market Share by Regions 2014-2019
Figure 2018 Global Tuberculosis Drug Sales Market Share by Regions
Table Global Tuberculosis Drug Revenue by Regions 2014-2019 (Million US$)
Table Global Tuberculosis Drug Revenue Market Share by Regions 2014-2019
Figure Global Tuberculosis Drug Revenue Market Share by Regions 2014-2019
Figure 2018 Global Tuberculosis Drug Revenue Market Share by Regions
Table Global Tuberculosis Drug Sales by Manufacturers (2014-2019) (K MT)
Table Global Tuberculosis Drug Sales Share by Manufacturers (2014-2019)
Figure Global Tuberculosis Drug Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Tuberculosis Drug Revenue by Manufacturers (2014-2019) (Million USD)
Table Tuberculosis Drug Revenue Share by Manufacturers (2014-2019)
Figure Tuberculosis Drug Value Share by Manufacturers in 2018
Table Key Manufacturers Tuberculosis Drug Price (2014-2019) (USD/MT)
Table Tuberculosis Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Tuberculosis Drug Product Type
Table Date of International Manufacturers Enter into Tuberculosis Drug Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Tuberculosis Drug Sales by Product (2014-2019) (K MT)
Table Global Tuberculosis Drug Sales Share by Product (2014-2019)
Figure Global Tuberculosis Drug Sales Market Share by Product (2014-2019)
Figure Global Tuberculosis Drug Sales Market Share by Product in 2018
Table Global Tuberculosis Drug Revenue by Product (2014-2019) (Million US$)
Table Global Tuberculosis Drug Revenue Share by Product (2014-2019)
Figure Global Tuberculosis Drug Revenue Market Share by Product (2014-2019)
Figure Global Tuberculosis Drug Revenue Market Share by Product in 2018
Table Tuberculosis Drug Price by Product 2014-2019 (USD/MT)
Table Global Tuberculosis Drug Sales by End User (2014-2019) (K MT)
Table Global Tuberculosis Drug Sales Share by End User (2014-2019)
Figure Global Sales Tuberculosis Drug Market Share by End User (2014-2019)
Figure Global Sales Tuberculosis Drug Market Share by End User in 2018
Figure North America Tuberculosis Drug Sales Growth Rate 2014-2019 (K MT)
Figure North America Tuberculosis Drug Revenue Growth Rate 2014-2019 (Million US$)
Table North America Tuberculosis Drug Sales by Countries (2014-2019) (K MT)
Table North America Tuberculosis Drug Sales Market Share by Countries (2014-2019)
Figure 2018 North America Tuberculosis Drug Sales Market Share by Countries
Table North America Tuberculosis Drug Revenue by Countries (2014-2019) (Million US$)
Table North America Tuberculosis Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Tuberculosis Drug Revenue Market Share by Countries
Figure United States Tuberculosis Drug Sales Growth Rate (2014-2019) (K MT)
Figure United States Tuberculosis Drug Revenue Growth Rate (2014-2019) (K MT)
Figure Canada Tuberculosis Drug Sales Growth Rate (2014-2019) (K MT)
Figure Canada Tuberculosis Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Tuberculosis Drug Sales Growth Rate (2014-2019) (K MT)
Figure Mexico Tuberculosis Drug Revenue Growth Rate (2014-2019) (Million US$)
Table North America Tuberculosis Drug Sales by Product (2014-2019) (K MT)
Table North America Tuberculosis Drug Sales Market Share by Product (2014-2019)
Figure 2018 North America Tuberculosis Drug Market Share by Product
Table North America Tuberculosis Drug Sales by End User (2014-2019) (K MT)
Table North America Tuberculosis Drug Sales Market Share by End User (2014-2019)
Figure 2018 North America Tuberculosis Drug Market Share by End User
Figure Europe Tuberculosis Drug Sales Growth Rate 2014-2019 (K MT)
Figure Europe Tuberculosis Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Tuberculosis Drug Sales by Countries (2014-2019) (K MT)
Table Europe Tuberculosis Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Tuberculosis Drug Sales Market Share by Countries
Table Europe Tuberculosis Drug Revenue by Countries (2014-2019) (Million US$)
Table Europe Tuberculosis Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Tuberculosis Drug Revenue Market Share by Countries
Figure Germany Tuberculosis Drug Sales Growth Rate (2014-2019) (K MT)
Figure Germany Tuberculosis Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure France Tuberculosis Drug Sales Growth Rate (2014-2019) (K MT)
Figure France Tuberculosis Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Tuberculosis Drug Sales Growth Rate (2014-2019) (K MT)
Figure UK Tuberculosis Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Tuberculosis Drug Sales Growth Rate (2014-2019) (K MT)
Figure Italy Tuberculosis Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Tuberculosis Drug Sales Growth Rate (2014-2019) (K MT)
Figure Russia Tuberculosis Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Tuberculosis Drug Sales by Product (2014-2019) (K MT)
Table Europe Tuberculosis Drug Sales Market Share by Product (2014-2019)
Figure 2018 Europe Tuberculosis Drug Market Share by Product
Table Europe Tuberculosis Drug Sales by End User (2014-2019) (K MT)
Table Europe Tuberculosis Drug Sales Market Share by End User (2014-2019)
Figure 2018 Europe Tuberculosis Drug Market Share by End User
Figure Asia Pacific Tuberculosis Drug Sales Growth Rate 2014-2019 (K MT)
Figure Asia Pacific Tuberculosis Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Tuberculosis Drug Sales by Countries (2014-2019) (K MT)
Table Asia Pacific Tuberculosis Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Tuberculosis Drug Sales Market Share by Countries
Table Asia Pacific Tuberculosis Drug Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Tuberculosis Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Tuberculosis Drug Revenue Market Share by Countries
Figure China Tuberculosis Drug Sales Growth Rate (2014-2019) (K MT)
Figure China Tuberculosis Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Tuberculosis Drug Sales Growth Rate (2014-2019) (K MT)
Figure Japan Tuberculosis Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Tuberculosis Drug Sales Growth Rate (2014-2019) (K MT)
Figure Korea Tuberculosis Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure India Tuberculosis Drug Sales Growth Rate (2014-2019) (K MT)
Figure India Tuberculosis Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Tuberculosis Drug Sales Growth Rate (2014-2019) (K MT)
Figure Australia Tuberculosis Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Tuberculosis Drug Sales Growth Rate (2014-2019) (K MT)
Figure Indonesia Tuberculosis Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Tuberculosis Drug Sales Growth Rate (2014-2019) (K MT)
Figure Malaysia Tuberculosis Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Tuberculosis Drug Sales Growth Rate (2014-2019) (K MT)
Figure Philippines Tuberculosis Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Tuberculosis Drug Sales Growth Rate (2014-2019) (K MT)
Figure Thailand Tuberculosis Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Tuberculosis Drug Sales Growth Rate (2014-2019) (K MT)
Figure Vietnam Tuberculosis Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Tuberculosis Drug Sales Growth Rate (2014-2019) (K MT)
Figure Singapore Tuberculosis Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Tuberculosis Drug Sales by Product (2014-2019) (K MT)
Table Asia Pacific Tuberculosis Drug Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Tuberculosis Drug Market Share by Product
Table Asia Pacific Tuberculosis Drug Sales by End User (2014-2019) (K MT)
Table Asia Pacific Tuberculosis Drug Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Tuberculosis Drug Market Share by End User
Figure Central & South America Tuberculosis Drug Sales Growth Rate 2014-2019 (K MT)
Figure Central & South America Tuberculosis Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Tuberculosis Drug Sales by Countries (2014-2019) (K MT)
Table Central & South America Tuberculosis Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Tuberculosis Drug Sales Market Share by Countries
Table Central & South America Tuberculosis Drug Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Tuberculosis Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Tuberculosis Drug Revenue Market Share by Countries
Figure Brazil Tuberculosis Drug Sales Growth Rate (2014-2019) (K MT)
Figure Brazil Tuberculosis Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Tuberculosis Drug Sales Growth Rate (2014-2019) (K MT)
Figure Argentina Tuberculosis Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Tuberculosis Drug Sales by Product (2014-2019) (K MT)
Table Central & South America Tuberculosis Drug Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Tuberculosis Drug Market Share by Product
Table Central & South America Tuberculosis Drug Sales by End User (2014-2019) (K MT)
Table Central & South America Tuberculosis Drug Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Tuberculosis Drug Market Share by End User
Figure Middle East and Africa Tuberculosis Drug Sales Growth Rate 2014-2019 (K MT)
Figure Middle East and Africa Tuberculosis Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Tuberculosis Drug Sales by Countries (2014-2019) (K MT)
Table Middle East and Africa Tuberculosis Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Tuberculosis Drug Sales Market Share by Countries
Table Middle East and Africa Tuberculosis Drug Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Tuberculosis Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Tuberculosis Drug Revenue Market Share by Countries
Figure GCC Countries Tuberculosis Drug Sales Growth Rate (2014-2019) (K MT)
Figure GCC Countries Tuberculosis Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Tuberculosis Drug Sales Growth Rate (2014-2019) (K MT)
Figure Turkey Tuberculosis Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Tuberculosis Drug Sales Growth Rate (2014-2019) (K MT)
Figure Egypt Tuberculosis Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Tuberculosis Drug Sales Growth Rate (2014-2019) (K MT)
Figure South Africa Tuberculosis Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Tuberculosis Drug Sales by Product (2014-2019) (K MT)
Table Middle East and Africa Tuberculosis Drug Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Tuberculosis Drug Market Share by Product
Table Middle East and Africa Tuberculosis Drug Sales by End User (2014-2019) (K MT)
Table Middle East and Africa Tuberculosis Drug Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Tuberculosis Drug Market Share by End User
Table Lupin Company Details
Table Lupin Tuberculosis Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Lupin Recent Development

Table Otsuka Novel Products Company Details
Table Otsuka Novel Products Tuberculosis Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Otsuka Novel Products Recent Development

Table Pfizer Company Details
Table Pfizer Tuberculosis Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Pfizer Recent Development

Table Sanofi Company Details
Table Sanofi Tuberculosis Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Sanofi Recent Development

Table Global Tuberculosis Drug Sales Forecast by Regions 2019-2025 (K MT)
Table Global Tuberculosis Drug Sales Market Share Forecast by Regions 2019-2025
Table Global Tuberculosis Drug Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Tuberculosis Drug Revenue Market Share Forecast by Regions 2019-2025
Table Global Tuberculosis Drug Sales Forecast by Product 2019-2025 (K MT)
Table Global Tuberculosis Drug Sales Market Share Forecast by Product 2019-2025
Table Global Tuberculosis Drug Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Tuberculosis Drug Revenue Market Share Forecast by Product 2019-2025
Table Global Tuberculosis Drug Sales Forecast by End User 2019-2025 (K MT)
Table Global Tuberculosis Drug Sales Market Share Forecast by End User 2019-2025
Figure North America Tuberculosis Drug Sales Growth Rate Forecast (2019-2025) (K MT)
Figure North America Tuberculosis Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Tuberculosis Drug Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Europe Tuberculosis Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Tuberculosis Drug Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Asia Pacific Tuberculosis Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Tuberculosis Drug Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Central & South America Tuberculosis Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Tuberculosis Drug Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Middle East and Africa Tuberculosis Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Tuberculosis Drug Value Chain
Table Tuberculosis Drug Customers List
Table Tuberculosis Drug Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Choose License Type